These drugs are more suitable for long-term use as studies have shown that about two-thirds of people regain the lost weight once the drug is stopped
The eye test isnt always accurate, but visual changes in your body are often a sign that youre making body composition changes
Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1r) in the rat brain
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
However, this article should not be used as a substitute for the knowledge and expertise of a licensed healthcare professional
SACRAMENTO Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year
